Vx-001

N/A

Report date: 2025/02/06 10:15:53

Base Information

Drug NameVx-001
Drug Alias NameTERT572YVx-001/hTERThTERT572Y/hTERT572Human telomerase reverse transcriptase 572YVx-001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsTelomerase reverse transcriptase inhibitors
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaPolandRomania +[8] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVaxon Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxon Biotech
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A